Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2010 07:59 ET | Source: Marina Biotech, Inc.

Marina Biotech Acquires RNA Delivery Assets of Novosom AG

BOTHELL, WA--(Marketwire - July 28, 2010) - Marina Biotech, Inc. (NASDAQ: MRNAD) announced today that the Company has acquired the intellectual property of Novosom AG of Halle, Germany for its...
July 27, 2010 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech and University of Helsinki Expand Collaboration to Discover Novel Targeting Peptides With Marina's Proprietary Trp Cage Library

BOTHELL, WA--(Marketwire - July 27, 2010) - Marina Biotech, Inc. (NASDAQ: MRNAD) (formerly known as MDRNA, Inc.) and Dr. Pirjo Laakkonen at the University of Helsinki Biomedicum in Finland today...
July 22, 2010 08:56 ET | Source: Marina Biotech, Inc.

MDRNA, Inc. Shareholders Approve Acquisition of Cequent Pharmaceuticals

BOTHELL, WA--(Marketwire - July 22, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced that, at the Company's Annual Meeting of...
July 19, 2010 18:04 ET | Source: MDRNA, Inc.

MDRNA, Inc. Encourages Stockholders to Vote Their Shares

BOTHELL, WA--(Marketwire - July 19, 2010) - MDRNA, Inc.(NASDAQ: MRNA) announced today that it is encouraging all stockholders to promptly submit their voting instructions for the annual meeting of...
June 09, 2010 08:30 ET | Source: MDRNA, Inc.

MDRNA, Inc. Expands Its Proprietary UNA Intellectual Property Portfolio by Acquiring Exclusive Rights to UNA-Based Diagnostics

BOTHELL, WA--(Marketwire - June 9, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it obtained exclusive rights to develop, make,...
June 02, 2010 09:00 ET | Source: MDRNA, Inc.

MDRNA, Inc. to Present at 9th Annual Needham Healthcare Conference

BOTHELL, WA--(Marketwire - June 2, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that it will be presenting at the 9th Annual Needham...
May 13, 2010 16:02 ET | Source: MDRNA, Inc.

MDRNA, Inc. Announces First Quarter 2010 Financial Results

BOTHELL, WA--(Marketwire - May 13, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today reported financial results for the first quarter ended March...
May 12, 2010 08:00 ET | Source: MDRNA, Inc.

MDRNA, Inc. Selected as a "Best and Brightest" Technology Leader

BOTHELL, WA--(Marketwire - May 12, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today reported that MDRNA was chosen as a "Best and Brightest"...
May 06, 2010 08:00 ET | Source: MDRNA, Inc.

MDRNA, Inc. Reports Novel Target Specificity Characteristics of Its Proprietary UsiRNA Technology for RNAi-based Therapeutics

BOTHELL, WA--(Marketwire - May 6, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today reported on advances made with the Company's proprietary...
May 05, 2010 08:30 ET | Source: MDRNA, Inc.

MDRNA, Inc. to Report First Quarter Results on May 13, 2010 at 4:30 p.m. Eastern Time

BOTHELL, WA--(Marketwire - May 5, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that it will host a conference call with...